Randomized study on hydroxyurea alone versus hydroxyurea combined with low-dose interferon-α2b for chronic myeloid leukemia
Benelux CML Study Group - … Journal of the American Society of …, 1998 - ashpublications.org
Interferon-α (IFN-α) is considered the standard therapy for chronic myeloid leukemia (CML)
patients not suitable for allogeneic stem cell transplantation. From 1987 through 1992, 195 …
patients not suitable for allogeneic stem cell transplantation. From 1987 through 1992, 195 …
Randomized study on hydroxyurea alone versus hydroxyurea combined with low-dose interferon-alpha 2b for chronic myeloid leukemia. The Benelux CML Study …
Blood, 1998 - europepmc.org
A comment on this article appears in" Questions raised by the Benelux CML Study Group:
results from the randomized study with hydroxyurea alone versus hydroxyurea combined …
results from the randomized study with hydroxyurea alone versus hydroxyurea combined …
[HTML][HTML] Randomized Study on Hydroxyurea Alone Versus Hydroxyurea Combined With Low-Dose Interferon-α2b for Chronic Myeloid Leukemia
Benelux CML Study Group - Blood, 1998 - Elsevier
Interferon-α (IFN-α) is considered the standard therapy for chronic myeloid leukemia (CML)
patients not suitable for allogeneic stem cell transplantation. From 1987 through 1992, 195 …
patients not suitable for allogeneic stem cell transplantation. From 1987 through 1992, 195 …
Randomized study on hydroxyurea alone versus hydroxyurea combined with low-dose interferon-alpha 2b for chronic myeloid leukemia
JC Kluin-Nelemans, A Delannoy, A Louwagie… - Blood, 1998 - research.rug.nl
Abstract Interferon-alpha (IFN-alpha) is considered the standard therapy for chronic myeloid
leukemia (CML) patients not suitable for allogeneic stem cell transplantation. From 1987 …
leukemia (CML) patients not suitable for allogeneic stem cell transplantation. From 1987 …